|
DPP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.21890000712466E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40730005426803E-09 |
| Normal-vs-Stage2 |
1.88825999999365E-05 |
| Normal-vs-Stage3 |
1.621980E-04 |
| Normal-vs-Stage4 |
2.179000E-04 |
| Stage1-vs-Stage2 |
8.315800E-01 |
| Stage1-vs-Stage3 |
3.728000E-01 |
| Stage1-vs-Stage4 |
8.819000E-01 |
| Stage2-vs-Stage3 |
5.840800E-01 |
| Stage2-vs-Stage4 |
7.547800E-01 |
| Stage3-vs-Stage4 |
4.739000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.71450004088558E-09 |
| Normal-vs-AfricanAmerican |
1.07350000000395E-07 |
| Normal-vs-Asian |
8.353900E-04 |
| Caucasian-vs-AfricanAmerican |
8.557600E-01 |
| Caucasian-vs-Asian |
6.347600E-01 |
| AfricanAmerican-vs-Asian |
6.804600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00620001219909E-09 |
| Normal-vs-Female |
6.640400E-04 |
| Male-vs-Female |
6.420900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.5608999999992E-05 |
| Normal-vs-Extreme_Weight |
9.22190102059517E-11 |
| Normal-vs-Obese |
2.53859999999051E-06 |
| Normal-vs-Extreme_Obese |
5.69109999999373E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.434800E-01 |
| Normal_Weight-vs-Obese |
6.789800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.325400E-01 |
| Extreme_Weight-vs-Obese |
4.298000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.939200E-01 |
| Obese-vs-Extreme_Obese |
3.448600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.002250E-04 |
| Normal-vs-Age(41-60Yrs) |
1.74660000018534E-07 |
| Normal-vs-Age(61-80Yrs) |
1.08700004552986E-09 |
| Normal-vs-Age(81-100Yrs) |
1.02530000001266E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.678800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.539400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.250200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.939770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.293600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.955400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67230007619423E-10 |
| Normal-VS-Type2 PRCC |
1.7404700000001E-05 |
| Normal-VS-KIRP CIMP |
2.215400E-03 |
| Normal-VS-Unclassified PRCC |
1.076880E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.357900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.287800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.400500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.239000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.200400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.185000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56159973840886E-10 |
| Normal-vs-N1 |
9.762300E-04 |
| Normal-vs-N2 |
4.000400E-04 |
| N0-vs-N1 |
2.729600E-02 |
| N0-vs-N2 |
6.110400E-01 |
| N1-vs-N2 |
1.807040E-01 |
|
|
